Heart rehab trial aims to boost life quality for amyloidosis patients

NCT ID NCT07494942

First seen Apr 03, 2026 · Last updated May 17, 2026 · Updated 5 times

Summary

This study tests whether a 5-week cardiac rehabilitation program can improve exercise ability and quality of life in adults with cardiac amyloidosis. Researchers will measure heart and lung function, symptoms, and well-being before and after the program. The goal is to see if this approach is safe and helpful for managing this serious heart condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • KRIEF

    Montpellier, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.